GC Cell

GC Cell Dividend Yield

The Dividend Yield of GC Cell (144510.KQ) as of Nov 2, 2026 is 0.41 %. In the previous year, Dividend Yield was 1.43 % — a change of -71.43% (lower).

Dividend Yield

0.41 %

YoY

-71.43%

Last updated:

Dividend Yield of GC Cell is 2023 0.41 % . Dividend Yield of GC Cell was 2022 1.43 % . It decreases by -71.43% lower compared to the previous year.

The GC Cell Dividend Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Yield
Date
Dividend Yield
Jan 1, 2016
0.31 KRW
Jan 1, 2017
0.20 KRW
Jan 1, 2018
0.14 KRW
Jan 1, 2019
0.10 KRW
Jan 1, 2020
0.41 KRW
Jan 1, 2022
1.43 KRW
Jan 1, 2023
0.41 KRW
The GC Cell Dividend Yield history
YEARDividend YieldYoY
0.41 %-71.43%
1.43 %+250.00%
0.41 %+300.00%
0.10 %-28.57%
0.14 %-30.00%
0.20 %-33.33%
0.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GC Cell Stock analysis

What does GC Cell do? GC Cell Corp generates revenue through four business segments. The Specimen Testing Service segment offers sample testing, clinical trial support, and veterinary testing services to clients in healthcare and research sectors. The Cell Therapy segment provides cell culture solutions and technology transfer services to biotechnology firms. The Cord Blood Storage segment delivers cord blood storage services primarily to expectant parents and medical institutions. The Other Business segment handles bio-logistics services and related operations for healthcare providers. The company's revenue streams are derived from direct contracts with healthcare organizations, biotech companies, and individual clients seeking specialized testing and storage solutions. Clients include hospitals, research institutions, and private individuals requiring cord blood preservation. The firm's business model focuses on providing specialized services within the life sciences sector without relying on external partnerships or third-party platforms. GC Cell Corp's product offerings are tailored to specific industry needs, with each segment targeting distinct client groups. The Specimen Testing Service segment serves clients needing laboratory analysis, while the Cell Therapy segment supports biotech innovation through technology transfer. The Cord Blood Storage segment caters to consumer demand for personal health preservation, and the Other Business segment facilitates logistics for medical supply chains. GC Cell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Cell stock

Dividend Yield of GC Cell is 0.41 % in 2023.

Dividend Yield of GC Cell changed from 1.43 % to 0.41 %, representing a -71.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Yield GC Cell since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's GC Cell historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — GC Cell

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — GC Cell